First Trust Advisors LP lessened its stake in Colgate-Palmolive (NYSE:CL) by 3.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 331,009 shares of the company’s stock after selling 11,811 shares during the quarter. First Trust Advisors LP’s holdings in Colgate-Palmolive were worth $24,114,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Renaissance Technologies LLC boosted its holdings in shares of Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after purchasing an additional 2,903,800 shares during the last quarter. APG Asset Management N.V. boosted its holdings in shares of Colgate-Palmolive by 243.0% in the 3rd quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock valued at $296,557,000 after purchasing an additional 2,884,100 shares during the last quarter. TIAA CREF Investment Management LLC boosted its holdings in shares of Colgate-Palmolive by 84.2% in the 1st quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock valued at $333,380,000 after purchasing an additional 2,082,262 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Colgate-Palmolive by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after acquiring an additional 1,621,392 shares in the last quarter. Finally, Swedbank acquired a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $102,014,000. Institutional investors own 72.84% of the company’s stock.

In related news, Director Stephen I. Sadove sold 20,780 shares of Colgate-Palmolive stock in a transaction on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the sale, the director now owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Victoria L. Dolan sold 10,000 shares of Colgate-Palmolive stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the sale, the insider now directly owns 60,528 shares in the company, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. Insiders have sold a total of 181,048 shares of company stock worth $13,168,995 in the last ninety days. 1.02% of the stock is currently owned by insiders.

Several research firms recently weighed in on CL. Deutsche Bank began coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Societe Generale lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price on the stock. in a report on Wednesday, November 29th. They noted that the move was a valuation call. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. Finally, Citigroup reduced their target price on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a report on Thursday, November 2nd. Two research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus price target of $76.04.

Shares of Colgate-Palmolive (CL) opened at $73.99 on Tuesday. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27. The stock has a market cap of $65,023.70, a price-to-earnings ratio of 25.80, a P/E/G ratio of 3.39 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the firm posted $0.73 EPS. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. analysts expect that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Colgate-Palmolive (CL) Shares Sold by First Trust Advisors LP” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/colgate-palmolive-cl-shares-sold-by-first-trust-advisors-lp/1772383.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.